<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00846001</url>
  </required_header>
  <id_info>
    <org_study_id>SACRT 022</org_study_id>
    <secondary_id>RU 001</secondary_id>
    <nct_id>NCT00846001</nct_id>
  </id_info>
  <brief_title>Resynchronization Surgery Combined Unified Efficacy</brief_title>
  <acronym>RESCUE</acronym>
  <official_title>Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare survivability and efficacy of the patients with severe
      ischemic heart failure after coronary artery bypass grafting alone and coronary artery bypass
      grafting with single-step implantation of CRT system (CABG alone vs CABG + CRT )
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term mortality</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mode of Death</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse cardiac events</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lead performance</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">178</enrollment>
  <condition>Ischemic Heart Failure</condition>
  <arm_group>
    <arm_group_label>CABG alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard coronary artery bypass grafting according guidelines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CABG+CRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard coronary artery bypass grafting according guidelines with concomitant three bipolar epicardial leads implantation for cardiac resynchronization therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary artery bypass grafting</intervention_name>
    <description>Standard coronary surgry according guidelines</description>
    <arm_group_label>CABG alone</arm_group_label>
    <arm_group_label>CABG+CRT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epicardial implantation of cardiac resynchronization therapy device</intervention_name>
    <description>During the cardiac surgery, the CABG+CRT arm patients will be implanted with epicardial leads to the right atrium, right and left ventricles. Left ventricle leads will be fixed to the posterolateral wall provided that there is no scar or fat tissue (behind and 2-3 cm apical than obtuse marginal artery). Right atrial and right ventricular leads will be fixed in a traditional way. Then the leads will be guided into a preformed pocket (left subclavian region) and connected with the CRT device.</description>
    <arm_group_label>CABG+CRT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women

          -  Age 18-80

          -  History of ischemic heart failure and indications for CABG

          -  LVEF less than 35% estimated by echocardiography measured within 3 months of study
             entry

          -  NYHA and CCS (angina) II-IV functional class

          -  Signs of dyssynchrony (at least one of the following three): QRS &gt; 120 ms or
             dyssynchrony based on Doppler-methods (Tissue Tracking and TSI methods) or CARE HF
             criteria: Aortic pre-ejection delay &gt;140ms, Interventricular mechanical delay &gt;40 ms,
             Delayed activation of postero-lateral LV wall

        Exclusion Criteria:

          -  Failure to provide informed consent.

          -  Previous cardiac surgery

          -  Non-cardiac illness with a life expectancy of less than 3 year

          -  Non-cardiac illness imposing substantial operative mortality

          -  Previous heart, kidney, liver, or lung transplantation

          -  Current participation in another clinical trial in which a patient is taking an
             investigational drug or receiving an investigational medical device

          -  Successful coronary revascularization (Ð¡ABG or PCI) within 12 months of study
             enrollment

          -  Chronic atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgeny A Pokushalov, MD, PhD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>State Research Institute of Circulation Pathology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Silesia</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Slovenia</country>
  </location_countries>
  <link>
    <url>http://meshalkinclinic.ru</url>
  </link>
  <results_reference>
    <citation>Pokushalov E, Romanov A, Prohorova D, Cherniavsky A, Goscinska-Bis K, Bis J, Bochenek A, Karaskov A. Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony. Eur J Cardiothorac Surg. 2010 Dec;38(6):773-80. doi: 10.1016/j.ejcts.2010.03.036. Epub 2010 May 6.</citation>
    <PMID>20447832</PMID>
  </results_reference>
  <results_reference>
    <citation>Pokushalov E, Romanov A, Prohorova D, Cherniavsky A, Karaskov A, Gersak B. Coronary artery bypass grafting with and without concomitant epicardial cardiac resynchronization therapy in patients with ischemic cardiomyopathy: a randomized study. Heart Surg Forum. 2010 Jun;13(3):E177-84. doi: 10.1532/HSF98.20091149.</citation>
    <PMID>20534420</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2009</study_first_submitted>
  <study_first_submitted_qc>February 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2009</study_first_posted>
  <last_update_submitted>July 14, 2015</last_update_submitted>
  <last_update_submitted_qc>July 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Resynchronization Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

